Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014Joseph Hayes, David Osborn|The British Journal of Psychiatry|2017Cited by 474
Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend studyAdrienne Y L Chan, Kenneth K. C. Man, Yogini Jani et al.|Nature Communications|2023Cited by 60
Use of gabapentinoid treatment and the risk of self-harm: population based self-controlled case series studyA. Yuen, Kenneth K. C. Man, Boqing Chen et al.|BMJ|2025Cited by 6